+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Pancreas Device System Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026

  • ID: 5147695
  • Report
  • September 2020
  • Region: Global
  • 150 pages
  • OG Analysis
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Beta Bionics
  • Bigfoot Biomedical Inc.
  • Cellnovo
  • Dexcom Inc
  • F. Hoffmann-La Roche Ltd
  • Inreda Diabetic B.V.
  • MORE
The study predicts the short term and long term trends that can shape the future of the Artificial Pancreas Device System market including the COVID-19 pandemic implications for the Artificial Pancreas Device Systems industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Artificial Pancreas Device System market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Artificial Pancreas Device System Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Artificial Pancreas Device System market forecast and Artificial Pancreas Device System market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020-2026 as the forecast period. The research was based on the findings of an expert team of analysts analyzing the Artificial Pancreas Device System market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Artificial Pancreas Device System industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening the Artificial Pancreas Device System market share in developed countries.

Scope of the Research

ARTIFICIAL PANCREAS DEVICES SYSTEM Market is analyzed and forecast over the outlook period from 2020 to 2026 by type including
CTR (CONTROL TO RANGE) SYSTEMS
CTT (CONTROL TO TARGET) SYSTEMS

ARTIFICIAL PANCREAS DEVICES SYSTEM Market is analyzed and forecast over the outlook period from 2020 to 2026 by END-USER including
HOSPITALS
MEDICAL CENTRES
OTHERS

Top Companies Operating in the Artificial Pancreas Device System market include BETA BIONICS, BIGFOOT BIOMEDICAL, INC., CELLNOVO, DEXCOM, INC, F. HOFFMANN-LA ROCHE LTD, INREDA DIABETIC B.V., INSULET CORP, JOHNSON & JOHNSON, MEDTRONIC PLC, TandEM DIABETES CARE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Beta Bionics
  • Bigfoot Biomedical Inc.
  • Cellnovo
  • Dexcom Inc
  • F. Hoffmann-La Roche Ltd
  • Inreda Diabetic B.V.
  • MORE
1. Table of Contents
1.1 List of Tables
1.2 List of Figures

2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Artificial Pancreas Device System Market- Key Findings, 2020

3. Strategic Imperatives on Global Artificial Pancreas Device System Market
3.1 Covid-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End-user Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Artificial Pancreas Device System Companies

4. Artificial Pancreas Devices System Market Value Outlook to 2026, by Type
4.1 Ctr (Control to Range) Systems
4.2 Ctt (Control to Target) Systems

5. Artificial Pancreas Devices System Market Value Outlook to 2026, by End-User
5.1 Hospitals
5.2 Medical Centres
5.3 Others

6 Asia-Pacific Artificial Pancreas Device System Market Value Outlook to 2026
6.1 Leading Artificial Pancreas Device System Types Contributing to Asia-Pacific Market
6.2 Top Applications Contributing to Asia-Pacific Artificial Pancreas Device System
6.3 Top Countries Contributing to Asia-Pacific Artificial Pancreas Device System

7 Europe Artificial Pancreas Device System Market Value Outlook to 2026
7.1 Leading Artificial Pancreas Device System Types Contributing to Europe Market
7.2 Top Applications Contributing to Europe Artificial Pancreas Device System
7.3 Top Countries Contributing to Europe Artificial Pancreas Device System

8 North America Artificial Pancreas Device System Market Value Outlook to 2026
8.1 Leading Artificial Pancreas Device System Types Contributing to North America Market
8.2 Top Applications Contributing to North America Artificial Pancreas Device System
8.3 Top Countries Contributing to North America Artificial Pancreas Device System

9 South and Central America Artificial Pancreas Device System Market Value Outlook to 2026
9.1 Leading Artificial Pancreas Device System Types Contributing to South and Central America Market
9.2 Top Applications Contributing to South and Central America Artificial Pancreas Device System
9.3 Top Countries Contributing to South and Central America Artificial Pancreas Device System

10 Middle East Africa Artificial Pancreas Device System Market Value Outlook to 2026
10.1 Leading Artificial Pancreas Device System Types Contributing to Middle East Africa Market
10.2 Top Applications Contributing to Middle East Africa Artificial Pancreas Device System
10.3 Top Countries Contributing to Middle East Africa Artificial Pancreas Device System

11 Business Profiles of Leading Companies
11.1 Business Description, SWOT and Financial Analysis of Companies in Artificial Pancreas Device System Market
11.2 Beta Bionics
11.3 Bigfoot Biomedical, Inc.
11.4 Cellnovo
11.5 Dexcom, Inc
11.6 F. Hoffmann-La Roche Ltd
11.7 Inreda Diabetic B.V.
11.8 Insulet Corp
11.9 Johnson & Johnson
11.10 Medtronic plc
11.11 Tandem Diabetes Care

12 Recent Industry Developments

13 Appendix
13.1 Analyst Expertise
13.2 Sources and Methodology
13.3 Contacts
Note: Product cover images may vary from those shown
3 of 4
  • Beta Bionics
  • Bigfoot Biomedical Inc.
  • Cellnovo
  • Dexcom Inc
  • F. Hoffmann-La Roche Ltd
  • Inreda Diabetic B.V.
  • Insulet Corp
  • Johnson & Johnson
  • Medtronic plc
  • Tandem Diabetes Care
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll